Skip to main content
. 2018 Feb 1;13(2):e0192278. doi: 10.1371/journal.pone.0192278

Fig 1. Study setup.

Fig 1

Eligible HIV+ individuals were recruited into the study. They were given 4 autologous dendritic cell vaccinations at 4 week intervals, followed by analytical treatment interruption (ATI). Plasma analytes were measured before vaccination (‘PreVac’), after the third vaccination (Vac#3), just after commencing ATI, and when plasma virus loads become detectable again (ATI+PVL). The bar indicates the phases around the sampling points that were used for summarizing the neutrophil counts (N1-5).